Background {#Sec1}
==========

Sevoflurane anesthesia in infant rats can result in long-term cognitive impairment, possibly by inhibiting neurogenesis \[[@CR1]\]. The hippocampus is critical for memory consolidation and is one of only two mammalian brain regions where neural stem cells (NSCs) are renewed continuously throughout life. Thereby, further studies with sevoflurane exposure of NSCs are necessary to confirm whether sevoflurane can influence apoptosis of neural cells.

GABA is an important endogenous amio acid of the central nervous system \[[@CR2],[@CR3]\], which could activate GABA~A~ receptor to produce inhibitory effects in the release of neurotransmitter \[[@CR4]\]. Sevoflurane repress spontaneous pre-motor neuronal activity by enhancing GABA~A~ receptor function \[[@CR5]\] thus enhancing the inhibitory effects of central nervous system and further inducing apoptosis of neural stem cells.

Apoptosis is directly regulated by Bcl-2 family proteins, including anti-apoptosis protein Bcl-2 and Bcl-xL and pro-apoptotic protein Bax and Bak \[[@CR6]\], which finally lead to the activation of Caspase-3 \[[@CR7]\]. However, whether neural stem cells exposed to sevoflurane cause significance of apoptosis is still unknown. In present study, we use NSCs exposed to sevoflurane to simulate infant sevoflurane anesthesia. Exploration of the mechanisms underneath can provide a novel way to protect our central nervous system against sevoflurane.

Methods {#Sec2}
=======

Materials {#Sec3}
---------

Cells Counting Kit-8 (CCK-8) and Annexin V-FITC Apoptosis Detection Kit were from Dojindo (Japan). Cells culture medium (DMEM/F12), B-27® Supplement without Vitamin A, and fetal bovine serum, were from Gibco (USA). Lactate Dehydrogenase (LDH) was from Beyotime (China). Epidermal Growth Factor (EGF), Fibroblast Growth Factor-basic (bFGF) were from PeproTech (USA).

The following antibodies were purchased as indicated: Rabbit anti-bcl-2 antibody, Mouse anti-bax antibody, Rabbit anti-caspase-3 and Rabbit anti-GAPDH polyclonal antibody were all from Abcam (USA). Rabbit anti-GABA~A~ Rα was from Santa Cruz (USA). Bicuculline was from Sigma (USA).

NSCs culture {#Sec4}
------------

All experimental procedures were approved by the Ethics Committee of Dezhou People's Hospital. Every effort was made to minimize the number of animals used and the suffering of the animals. All animals were used only once.

NSCs were derived from Wistar rat embryonic brains, cultured, and expanded. The rat embryos were decapitated on embryonic day 17 (E17), and the hippocampus was quickly removed and placed on a dish with ice cold Hank's balanced salt solution containing penicillin (100 U/ml)/streptomycin (100 ug/ml) \[[@CR8],[@CR9]\]. Next, the hippocampus was minced, incubated in 0.25% trypsin--ethylenediaminetetraacetic acid (trypsin/EDTA) for 5 min at 37°C and then incubated with 0.05% DNase for 5 min at 37°C. Minced cells were then centrifuged, and the cell pellet was washed twice with Dulbecco's phosphate buffered saline (DPBS). The isolated cells were seeded at 2 × 10^4^ cells/ml on 100-mm dishes with medium mixture F-12 (DMEM/F12, 1:1), 2% B-27, 1% penicillin (100 U/ml)/streptomycin (100 μg/ml), 20 ng/ml bFGF, 20 ng/ml EGF, maintained at 37°C in a 5% CO~2~ atmosphere. Medium, growth factors, and supplements were changed every 3 days during culture process.

Sevoflurane and bicuculline treatment {#Sec5}
-------------------------------------

NSCs culture plates were put into an airtight glass chamber with inlet and outlet connectors. The inlet port of the chamber was connected to an anesthesia machine (Cicero-EM 8060, Drager, Germany). Sevoflurane was delivered into chamber by a sevoflurane vaporizer attached to the anesthesia machine. The concentrations of sevoflurane in the chamber were detected at the chamber outlet port by using a gas monitor (PM 8060, Drager, Germany). NSCs were divided into four groups: sevoflurane (1MAC) group (Group S), bicuculline group (Group B), and a combination of sevoflurane and bicuculline group (Group S + B), dimethyl sulphoxide (Group D). The Group S was treated with sevoflurane (1MAC) mixed with 95% air/5% CO2 at 6 L/min for 0 h, 3 h, 6 h, and 12 h. The Group B was treated with bicuculline (10uM) and 95% air/5% CO2 at 6 L/min for 0 h, 3 h, 6 h, and 12 h. The Group S + B was treated with bicuculline (10uM) and sevoflurane mixed with 95% air/5% CO2 at 6 L/min for 0 h, 3 h, 6 h, and 12 h. The Group D was treated with dimethyl sulphoxide (10 uL/mL) for 0 h, 3 h, 6 h, and 12 h.

CCK-8 assay and lactate dehydrogenase (LDH) release assay {#Sec6}
---------------------------------------------------------

A CCK-8 10ul of the kit reagent was added to the live cells into 96-well plates, and the suspension NSCs (100 ul/well) were incubated for 3 h at 37°C 5% CO~2~. Cell viability was measured by the absorbance at 450 nm \[[@CR1]\].

A colorimetric assay kit was used to quantify the LDH released from the cultured NSCs. After treated with sevoflurane, bicuculline, and DMSO, NSCs were collected, then centrifuged at 400 g for 5 min. Suck the supernatant, and add 150 uL LDH release reagent to mix completely, then incubate at 37°C 5% CO~2~ for 1 h. After centrifuged at 400 g for 5 min again, suck the supernatant. Add 120 uL supernatant to 96-well plates. Cell cytotoxicity was measured by the absorbance at 490 nm. All results were normalized to the optical densities (OD) \[[@CR1]\].

Measurement of apoptosis by Annexin V/PI staining {#Sec7}
-------------------------------------------------

Annexin V/PI staining was measured with an FITC Annexin V Apoptosis Detection Kit \[[@CR10]\]. After treated with sevoflurane and Bicuculline, the NSCs were washed twice with PBS, and the concentration was adjusted to 1 × 10^6^ cells/ml with Annexin V binding solution. Then remove 195 ul cell suspensions to a new tube, add 5 ul Annexin V-FITC combination, add 10 ul PI solution. Cells were incubated in dark room for 15 min at room temperature before adding 300 ul Annexin V binding solution. Apoptosis ratio was measured by flow cytometry.

Western blotting analysis {#Sec8}
-------------------------

For the preparation of total cell extracts, samples were washed twice with cold PBS and lysed in appropriate amount of radio immunoprecipitation assay (RIPA) buffer supplemented with phenylmethanesulfonyl fluoride (PMSF) \[[@CR11]-[@CR13]\]. The lysate was collected and protein concentration was determined using a bicinchoninic acid protein assay kit. Equal amounts of protein were denatured and separated on 10% SDS-PAGE gels and then transferred to polyvinylidene difluoride membranes (Bio-Rad, Hercules, CA) at 100 V for 1 h. After blocking with skim milk (5%), proteins were incubated with respective primary antibodies in blocking solution, according to the manufacturer's recommendations. The appropriate horseradish peroxidase-conjugated secondary antibody was added to the filters followed by incubation for 2 h at room temperature with an appropriate dilution. After sequential washing of the membranes in T-PBS to remove excess secondary antibody, the signals were detected by chemiluminescence using the electrochemiluminescence (ECL) system. Relative band densities of the various proteins were measured from scanned films using Image J Software.

Statistical analysis {#Sec9}
--------------------

Representative experiments from at least three independent experiments are shown. Statistical analysis was performed using the SPSS 19.0 statistics package. All data are expressed as mean ± SD. Statistical differences were assessed using Student's t-tests or one-way analysis of variance (ANOVA), where appropriate among groups. A *P*-value \<0.05 was considered statistically significant.

Results {#Sec10}
=======

Viability of NSCs with sevofluane by CCK-8 assays {#Sec11}
-------------------------------------------------

To evaluate the viability of NSCs after sevoflurane treatment, the NSCs were incubated in 1MAC of sevoflurane for 0 h, 3 h, 6 h, and 12 h, and cell viability was measured using the CCK-8 assays. Compared with 0 h, the viability of NSCs exposed to sevoflurane at 1 MAC decreased in time-dependent way in Group S. Cell viability decreased 8% (*P* \< 0.05) (Figure [1](#Fig1){ref-type="fig"}A) at 3 h post exposure, 15% at 6 h (*P* \< 0.05) (Figure [1](#Fig1){ref-type="fig"}A), and 28% at 12 h (*P* \< 0.05) (Figure [1](#Fig1){ref-type="fig"}A). Compared with corresponding time point of Group S, the viability of NSCs increased in Group S + B (*P* \< 0.05) (Figure [1](#Fig1){ref-type="fig"}A). Compared with 0 h, the viability of NSCs exposed to DMSO for 3 h, 6 h, and 12 h did not change obviously in Group D (*P* \> 0.05) (Figure [1](#Fig1){ref-type="fig"}A). Compared with 0 h, the viability of NSCs exposed to bicuculline for 3 h, 6 h, and 12 h did not change obviously in Group B (*P* \> 0.05) (Figure [1](#Fig1){ref-type="fig"}A).Figure 1**Effects of sevoflurane on cell viability and cytotoxicity.** NSCs were exposed to sevoflurane with 1 MAC at 0, 3, 6, and 12 h. **A**: Cell viability was measured by CCK-8 assays. Compared with 0 h in Group S, \*P \<0.05; Compared with 0 h in Group B, &P \>0.05; Compared with 0 h in Group D, \#P \>0.05; compared with the corresponding time point in Group S, \#\#P \<0.05, &&P \<0.05 and \*\*P \<0.05 in Group S + B. **B**: Cytotoxicity was measured by LDH assays. Compared with 0 h in Group S, \*P \<0.05; Compared with 0 h in Group B, &P \>0.05; Compared with 0 h in Group D, \#P \>0.05; compared with the corresponding time point in Group S, \#\#P \<0.05, &&P \<0.05, \*\*P \<0.05 in Group S + B. Data are representative of 6 independent experiments.

Cytotoxicity of NSCs with Sevoflurane by LDH assays {#Sec12}
---------------------------------------------------

Cytotoxicity of Sevoflurane on NSCs was measured by LDH assays. LDH release in the culture media increased in Group S along with the time from 0 hour to 12 h. Cytotoxicity increased 1.2-fold at 3 h, 1.4-fold at 6 h (*P* \< 0.05) (Figure [1](#Fig1){ref-type="fig"}B), and 1.8-fold at 12 h (*P* \< 0.05) (Figure [1](#Fig1){ref-type="fig"}B). LDH release in the culture media was decreased in Group S + B compared with corresponding time of Group S, (*P* \< 0.05) (Figure [1](#Fig1){ref-type="fig"}B). Compared with 0 h, the cytotoxicity of NSCs exposed to DMSO for 3 h, 6 h, and 12 h did not change obviously in Group D (*P* \> 0.05) (Figure [1](#Fig1){ref-type="fig"}B). Compared with 0 h, the viability of NSCs exposed to bicuculline for 3 h, 6 h, and 12 h did not change obviously in Group B (*P* \> 0.05) (Figure [1](#Fig1){ref-type="fig"}A).

Apoptosis of NSCs with sevoflurane by annexin V/PI staining {#Sec13}
-----------------------------------------------------------

Annexin V/PI staining was measured by flow cytometry (Figure [2](#Fig2){ref-type="fig"}). The results were similar to the CCK-8 assay. Compared with 0 h, the NSCs exposed to sevoflurane for 3 to 12 hours displayed a decreased proportion of early and late apoptotic cells in Group S (*P* \< 0.05) (Figure [2](#Fig2){ref-type="fig"}), and the ratio of apoptosis could be reversed by bicuculline at all times points in Group S + B (*P* \< 0.05) (Figure [2](#Fig2){ref-type="fig"}).Figure 2**Bicuculine increases neuronal viability and reduces apoptosis in sevoflurane neurotoxicity.** NSCs were incubated with bicuculine before sevoflurane treatment. The cells were then labeled by Annexin V-FITC and propidium iodide (PI) in Group S and Group S + B. The apoptosis was determined by flow cytometry. **A**: Q1 and Q3 quadrants were represented for normal cells and death cells with red color; Q2 and Q4 quadrants were represented for viable apoptotic cells and non-viable apoptotic cells with blue color. **B**: The histogram represents the percentage of apoptotic cells. Compared with 0 h in Group S, \*P \<0.05. In Group S + B, compared with the corresponding time point in Group S, \#P \<0.05, \#\#P \<0.05 and &P \<0.05. Data are representative of 3 independent experiments.

Expression of GABA~A~ receptor in group S and group S + B {#Sec14}
---------------------------------------------------------

Activation of GABA~A~ receptor in response to sevoflurane exposure was reported to decrease the viability of NSCs. The protein level of GABA~A~ receptor in NSCs was measured by western blotting. The expression of GABA~A~ receptor exposed to sevoflurane was higher in Group S and Group S + B, compared with 0 h (*P* \< 0.05) (Figure [3](#Fig3){ref-type="fig"}). The expression of GABA~A~ receptor was higher in Group S compared with Group S + B pretreated with bicuculline for 2 h at 3 h, 6 h, and 12 h (*P* \< 0.05) (Figure [3](#Fig3){ref-type="fig"}).Figure 3**Effect of GABA**~**A**~**Receptor expression in Group S and Group S** + **B.** The expression of GABA~A~ Receptor was detected with exposure to sevoflurane. **A**: Representative Western blotting of GABA~A~ R expression in Group S and Group S + B. **B**: Densitometric analysis of GABA~A~ R expression relative to that of GAPDH. Sevoflurane could significantly activate GABA~A~ R. Compared with 0 h in Group S, \*P \<0.05. In Group S + B, compared with the corresponding time point in Group S, \#P \<0.05, \#\#P \<0.05 and &P \<0.05. Data are representative of 3 independent experiments.

Expression of Bcl-2, Bax and caspase-3 with the treatments of sevoflurane and bicuculline {#Sec15}
-----------------------------------------------------------------------------------------

Western blotting showed that exposure to 1MAC sevoflurane in GroupS induced the down regulation of Bcl-2 (Figure [4](#Fig4){ref-type="fig"}), and up regulation of Bax (Figure [4](#Fig4){ref-type="fig"}) and Caspase-3 (Figure [5](#Fig5){ref-type="fig"}), compared with 0 h (*P* \< 0.05). In Group S + B, the changes of Bcl-2, Bax and Caspase-3 expression was a relatively mild compared with Group S (*P* \< 0.05).Figure 4**Effect of Bcl**-**2 and Bax expression in Group S and Group S** + **B.** The expressions of Bcl-2 and Bax were detected with exposure to sevoflurane. **A** and **C**: Representative Western blotting of Bcl-2 and Bax expressions in Group S and Group S + B. **B** and **D**: Densitometric analysis of Bcl-2 and Bax expressions relative to that of GAPDH. Compared with 0 h in Group S, \*P \<0.05. In Group S + B, compared with the corresponding time point in Group S, \#P \<0.05, \#\#P \<0.05 and &P \<0.05. Data are representative of 3 independent experiments.Figure 5**Effect of Caspase**-**3 expression in Group S and Group S** + **B.** The expressions of Bcl-2 and Bax were detected with exposure to sevoflurane. **A**: Representative Western blotting of Caspase-3 expression in Group S and Group S + B. **B**: Densitometric analysis of Caspase-3 expression relative to that of GAPDH. Compared with 0 h in Group S, \*P \<0.05. In Group S + B, compared with the corresponding time point in Group S, \#P \<0.05, \#\#P \<0.05 and &P \<0.05. Data are representative of 3 independent experiments.

Discussion {#Sec16}
==========

Sevoflurane is a new type of fluorinated inhalation anesthetic allowing for more rapid emergence than previous drugs, due to its lower blood/gas solubility \[[@CR14],[@CR15]\]. Nowadays, more and more infants adopt sevoflurane inhalation anesthesia, while a series of problems arises. Recent studies showed that young children exposed to general anesthesia are at greater risk of learning deficits in adolescence \[[@CR16]\]. It showed that postnatal exposure of common sevoflurane anesthetic could cause widely neuronal apoptosis subsequent learning and memory disorders \[[@CR17]\].

The study of Statmann et al. demonstrated that early inhalational anesthesia can induce long-term, mainly hippocampus-dependent cognitive dysfunction in rodents \[[@CR18]\]. Postnatal hippocampal neurogenesis sustains hippocampal function throughout life \[[@CR19]\], thus protection of the hippocampal neurogenesis is very significant. Cognitive impairment following anesthetic exposure may be associated with suppression of survival, proliferation of hippocampal neural stem cells. In this study, we confirmed in rat hippocampus that the viability of NSCs exposed to sevoflurane decreased, and cytotoxicity of sevoflurane increased.

Previous studies have shown that inhalational anesthetics, such as sevoflurane and isoflurane, are very helpful for reduction of perioperative mortality \[[@CR20],[@CR21]\]. But sevoflurane anesthetics may also cause memory impairment by neurons lost in hippocampus through cells apoptosis \[[@CR17]\]. And, recent reports also showed that propofol and sevoflurane would trigger widespread apoptotic neurodegeneration throughout the developing brain \[[@CR22]-[@CR24]\]. However, the mechanism remained unknown. Our studies approved that exposure to sevoflurane could cause apoptosis of NSCs, and apoptosis rate increased in a time-dependent way.

Many researches had given us possible mechanisms of anesthetic-induced apoptosis of NSCs. Some anesthetic agents induce apoptosis by blocking N-methyl-D-aspartate (NMDA) receptor and activating GABA~A~ receptor \[[@CR25]\]. As a combination of NMDA receptor antagonist and GABA~A~ receptor agonists, inhalation anesthetic kills immature brain cells \[[@CR26],[@CR27]\]. But the mechanisms of sevoflurane-induced apoptosis of NSCs are currently unknown. In our study, we found that the expression of GABA~A~ reporters increased after exposure to sevoflurane in time-dependent way by western blotting. That is to say, sevoflurane could active the GABA~A~ receptors. Therefore, we assume that stimulation of GABA by consistently duration of sevoflurane may induce apoptosis.

Bcl-2 protein family is an important factor to regulate cell intrinsic pathway of apoptosis. The family consists of two members: one is anti-apoptotic protein Bcl-2, the other is pro-apoptotic molecular Bcl-2-associated X protein (Bax). The protein Bax received the apoptosis signal could transfer to mitochondrial outer membrane, open the channel of permeability, release cytochrome c, and induce apoptosis finally. The protein bcl-2 could combine with Bax to change its spatial conformation to improve the apoptosis \[[@CR28],[@CR29]\]. Expression of Bcl-2 or related anti-apoptotic proteins block cell death in response to many varieties \[[@CR30]\]. In sevoflurane treated rat pup, the expression of Bcl-2 was suppressed, suggesting that anesthetic exposure may accelerate the physiological apoptosis \[[@CR31]\]. In our study, we found that exposure under sevoflurane could increase the expression of pro-apoptotic molecular Bax, while decrease Bcl-2 expression by western blotting. That is to say, sevoflurane could cause apoptosis of NSCs by increasing Bax and decreasing Bcl-2.

Caspase-3 is a member of the Caspase family of aspartate-specific cysteine proteases that plays a central role in the execution of the apoptotic program \[[@CR31]\]. The GABA agonist ethanol activated Caspase-3 in progenitor cells \[[@CR32]\]. In sevoflurane treated rat pup, the expression of Caspase-3 increased, suggesting that anesthetic exposure may accelerate the physiological apoptosis \[[@CR33]\]. The cellular expression of Bcl-2 and activated Caspases likely mediate the increased vulnerability to neuronal apoptosis during synaptogenesis \[[@CR34]\]. Recent report indicated that it could active caspase-3 and decrease neuronal in the neonatal hippocampus, but did not affect subsequent behavioural performances in juvenile rats which exposed to 2.3% sevoflurane for 6 h \[[@CR35]\]. Consistently, we found that caspase-3 activated under exposure of sevoflurane by western blotting.

Bicuculline, which acts on the GABA~A~ receptor recognition site, is specific GABA~A~ receptor blockers \[[@CR36]\]. Thereby it could selectively block GABA~A~ receptor, inhibit activation of GABA~A~. Our study showed that GABA~A~ receptors could be prevented by bicuculline. Furthermore, bicuculline could block apoptosis of NSCs by increasing expression of Bcl-2 and decreasing expression of Bax and Caspase-3. For the first time, we provide a novel therapeutical way to protect NSCs against sevoflurane anesthesia.

Conclusions {#Sec17}
===========

This study indicates that exposure to sevoflurane causes the apoptosis of NSCs, and long-time exposure could aggravate the damage. Activation of GABA~A~ receptor can induce the apoptosis by increasing Bax and caspase-3 and decreasing Bcl-2. The specific blocker of GABA~A~ receptor bicuculline could ameliorate the apoptosis. Our results suggest that GABA~A~ receptor may be an important receptor in NSCs exposing to sevoflurane, inhibition of GABA~A~ receptor may be a novel and effective target.
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